Related Experiment Video
Updated: Oct 15, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Dietary and Chemoprevention Strategies for Breast Cancer Prevention
1Section of Medical Oncology, Rush Medical College, Chicago, Illinois 60612, USA.
Abstract:
Breast cancer is the most common cancer among American women. Strategies to eliminate or cure invasive breast cancer (eg, treatment of established disease and early detection) have been joined by a promising new approach, prevention. Epidemiologic studies have yet to demonstrate that dietary modification can reduce the risk of breast cancer, but important trials are ongoing. The chemoprevention program of the National Cancer Institute (NCI) has been underway for a decade. The discovery of biomarkers, or "intermediate endpoints," that can serve as surrogates for the ultimate endpoint, breast cancer, is crucial to the success of this program. The chemoprevention programs of NCI and the Division of Cancer Prevention and Control have identified promising cancer prevention compounds, many of which are being studied in clinical trials.
Insights
Preventing breast cancer is a new focus alongside treatment and early detection. Research is exploring dietary changes and compounds identified by the National Cancer Institute (NCI) chemoprevention program.
Area of Science:
- Oncology
- Preventive Medicine
- Epidemiology
Background:
- Breast cancer is the most common cancer in American women.
- Prevention is an emerging strategy complementing treatment and early detection.
- Dietary modification's role in breast cancer risk reduction requires further study.
Purpose of the Study:
- To highlight the National Cancer Institute's (NCI) decade-long chemoprevention program.
- To emphasize the importance of identifying biomarkers (intermediate endpoints) for breast cancer.
- To discuss promising compounds identified for cancer prevention.
Main Methods:
- Ongoing clinical trials are evaluating cancer prevention compounds.
- Epidemiologic studies are investigating dietary modification's impact.
- Biomarker discovery is crucial for assessing prevention efficacy.
Main Results:
- The NCI chemoprevention program has identified promising compounds.
- Several compounds are currently under investigation in clinical trials.
- Biomarkers are essential for evaluating the success of prevention strategies.
Conclusions:
- Cancer prevention, particularly through chemoprevention, is a vital area of research.
- Identifying reliable biomarkers is key to advancing breast cancer prevention.
- Ongoing trials and compound discovery hold promise for reducing breast cancer incidence.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Preventive Healthcare Services

